Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Edwards Lifesciences Corp    EW   US28176E1082

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Edwards Lifesciences Corp : Edwards Lifesciences to Host Earnings Conference Call on April 24, 2012

04/16/2012 | 04:28pm US/Eastern

IRVINE, CA, April 16, 2012

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 392053. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at or

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #
distributed by
React to this article
01/23 EDWARDS LIFESCIENCES : Patent Issued for Device and Method for Improving Heart V..
01/23 EDWARDS LIFESCIENCES : Trademark Application for "EIP" Filed by Edwards Lifescie..
01/23 EDWARDS LIFESCIENCES : Patent Issued for Reduced Dehiscence Annuloplasty Ring
01/20 EDWARDS LIFESCIENCES : To Host Earnings Conference Call On February 3, 2015
01/08 EDWARDS LIFESCIENCES : Patent Issued for Physiologic Tricuspid Annuloplasty Ring
2014 EDWARDS LIFESCIENCES : Assigned Patent
2014 EDWARDS LIFESCIENCES : Outlines Growth Strategy at Annual Investor Conference
2014 EDWARDS LIFESCIENCES : Researchers Submit Patent Application, "Preparation and M..
2014 EDWARDS LIFESCIENCES : CardioKinetix Completes $50 Million Financing and Signs A..
2014 EDWARDS LIFESCIENCES : Patent Issued for Flux Limiting Membrane for Intravenous ..
Duration : Period :
Edwards Lifesciences Corp Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes